London, UK--(Marketwire - June 27, 2007) - FOR IMMEDIATE RELEASE
SkyePharma - Appointment of New Non-Executive Director
LONDON, UK, Wednesday, June 27, 2007 - SkyePharma PLC (LSE: SKP) today announces
that it will appoint a new Non-Executive Director, Jean-Charles Tschudin, with
effect from 1 July 2007.
Jean-Charles, 64, is an experienced senior-level pharmaceutical executive with
over 40 years' experience in the pharmaceutical industry, most recently with as
President and Chief Operating Officer of Yamanouchi Europe, the largest Japanese
pharmaceutical company in Europe. Prior to that he held senior positions at
Cardinal Health, Johnson & Johnson and Schering-Plough.
Jean-Charles will be appointed as a member of the Audit and Nomination &
Governance Committees.
No disclosures are required under section 9.6.13 of the Listing Rules.
The Company is committed to further strengthening its Board and continues to
seek to appoint an additional non-executive director.
Dr Jerry Karabelas, Chairman of SkyePharma, said: "On behalf of the whole Board
and staff, I would like to welcome Jean-Charles to the Board of SkyePharma. His
experience as a senior international manager in the pharmaceutical industry will
enable him to make a substantive contribution to the future of SkyePharma."
For further information please contact:
SkyePharma PLC Frank Condella +44 20 7491 1777
Ken Cunningham
Peter Grant
Financial Dynamics
(UK Enquiries) David Yates +44 20 7831 3113
Deborah Scott
Trout Group
(US Enquiries) Christine Labaree +1 617 583 1308
Seth Lewis
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new
formulations of known molecules to provide a clinical advantage and life-cycle
extension. The Company has eleven approved products in the areas of oral,
inhalation and topical delivery. The Group's products are marketed throughout
the world by leading pharmaceutical companies.
For more information, visit
www.skyepharma.com